Bluebird stops studies of sickle cell gene therapy after new cancer cases

Bluebird stops studies of sickle cell gene therapy after new cancer cases

Source: 
BioPharma Dive
snippet: 

Bluebird bio has stopped two clinical studies of its gene therapy for sickle cell disease after one participant developed leukemia and researchers reported another has a cancer-like disease of the bone marrow.